Epirubicin for the Treatment of Sepsis & Septic Shock

NCT05033808 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Sepsis

Interventions

DRUG: Epirubicin
DRUG: Placebo

Sponsor

Jena University Hospital

Collaborators

[object Object]
[object Object]